The Journal of the Korean bone and joint tumor society (대한골관절종양학회지)

The Korean Musculoskeletal Tumor Society (대한근골격종양학회)
권호 표지
DOI QR코드

DOI QR Code

The Significance of Sentinel Node Biopsy in Malignant Melanoma and Squamous Cell Carcinoma of Lower Extremities

하지에 발생한 악성흑색종 및 편평상피세포암에서 소속 림프절 생검의 의미

  • Kim, Jae-Do (Department of Orthopedic Surgery, Kosin University Gospel Hospital) ;
  • Lee, Gun-Woo (Department of Orthopedic Surgery, Kosin University Gospel Hospital) ;
  • Kwon, Young-Ho (Department of Orthopedic Surgery, Kosin University Gospel Hospital) ;
  • Chung, So-Hak (Department of Orthopedic Surgery, Kosin University Gospel Hospital)
  • 김재도 (고신대학교 복음병원 정형외과학교실) ;
  • 이근우 (고신대학교 복음병원 정형외과학교실) ;
  • 권영호 (고신대학교 복음병원 정형외과학교실) ;
  • 정소학 (고신대학교 복음병원 정형외과학교실)
  • Received : 2010.08.31
  • Accepted : 2010.10.27
  • Published : 2010.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Sentinel lymph node (SLNB) is the first confronted lymph node from primary lesion of tumor through lymphatic drainage, which is important for determining early metastasis and setting guidelines for treatment. We reported significant of sentinel lymph node biopsy in malignant melanoma (MM) and squamous cell carcinoma (SCC) of lower extremities. Materials and Methods: Twenty-five cases of surgically treatment and being possible for follow up more than 1 year among the patients who were diagnosed as MM and SCC in this institution from Sep. 2005 to Jan. 2009, and 10 cases of them were performed SLNB. Average age was 64 years old, and 15 cases of male and 10 cases of female were in this group. Results: 3 years overall survival rate was 100% and 3 years disease-free survival rate was 76%. Metastasis occurred in total 6 patients, 4 cases of inguinal lymph nodes, 1 case of soft tissue around knee, 1 case of left achilles tendon. In 15 cases of not performing SLNB, overall survival rate was 93.3% and disease-free survival rate was 73.3%. In 10 cases of performing SLNB, overall survival rate was 100% and disease-free survival rate was 90%. And only 1 case showed positive finding in the biopsy, and none of the 10 cases showed metastasis in follow-up. Conclusion: SLNB leads simpler and less complications compared to prior elective lymph node dissection, and shows high degree of accuracy. Throughout the SLNB, setting guidelines for treatment by accurate staging is thought to be helpful for increasing the survival rate in the patient with MM and SCC.

목적: 사지에 발생된 편평 상피암이나 악성 흑색종에서 술 중 소속 림프절 생검의 의미에 대해 알아보고자 한다. 대상 및 방법: 2005년 9월부터 2009년 1월까지 본원에서 악성 흑색종 또는 편평상피세포암으로 진단된 환자 중, 원발 부위의 광범위 절제술을 시행한 이후 술 후 면역항암화학요법을 시행하고 1년 이상 추시가 가능하였던 악성 흑색종 15예, 편평상피암 10예, 총 25예를 대상으로 하였고, 이 중 소속 림프절 생검을 시행한 군은 10예였다. 평균 연령은 64세였으며, 남자 15예, 여자 10예였다. 결과: 총 25예의 3년 생존율은 100%였고, 3년 무병 생존율는 76%였다. 총 6예에서 전이가 발생하였고, 서혜부 림프절 4예, 슬부 주위 연부조직 1예, 좌측 아킬레스건 1예였다. 소속 림프절 절제술을 시행하지 않았던 15예에서는 평균 생존율은 93.3%였고, 무병 생존율은 73.3%였다. 소속 림프절 절제술을 시행한 10예에서 평균 생존율은 100%였고, 무병 생존율은 90%였다. 술 중 소속 림프절 절제술을 시행한 10예 중 단 1예에서만 조직검사 상 양성 소견을 보였고, 소속 림프절 절제술을 시행하였던 10예 모두에서 추시 상 전이는 없었다. 소속 림프절 절제술 이후 합병증이 발생한 경우는 없었다. 결론: 소속 림프절의 생검 및 절제는 과거의 전 림프절 절제술과 비교하여 간단하고 적은 합병증으로 높은 정확도를 보이며, 종양의 정확한 병기 설정으로 치료 방향을 결정하는 것이 환자의 생존율을 높이는데 도움을 줄 수 있다고 판단된다.

Keywords

References

  1. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med. 2001;344:975-83. https://doi.org/10.1056/NEJM200103293441306
  2. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamaous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32:1309-21. https://doi.org/10.1111/j.1524-4725.2006.32300.x
  3. Roka F, Kittler H, Cauzig P, et al. Sentinel node status in melanoma patients is not predictive for overall survival upon multivatiate analysis. Br J Cancer. 2005;92:662-7. https://doi.org/10.1038/sj.bjc.6602391
  4. Morton DL, Cagle L, Wong J. Intraoperative lymphatic mapping and selective lymphadenectomy: technical details of a new procedure for clinical stage I melanoma. Presented at the 42nd Annual Meeting of the Society of Surgical Oncology, Washington DC; 1990.
  5. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-9. https://doi.org/10.1001/archsurg.1992.01420040034005
  6. Kwon YH, Kim JR, Lee YG, Kim JD. Analysis of treatment and prognosis in malignant melanoma. J Korean Bone & Joint Tumor Soc. 2005;11:141-7.
  7. Cochran AJ, Essner R, Ross DM, et al. Principle of sentinel lymph node identification: background and clinical implications. Langenbeck's Arch Surg. 2000;385:252-60. https://doi.org/10.1007/s004230000143
  8. Balch CM, Milton GW, Cascinelli N, et al. Elective lymph node dissection: pros and cons. Cutaneous melanoma. 2nd ed. Philadelphia: Lippincott; 1992. 345-66.
  9. Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of Stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc. 1986;61:697-705. https://doi.org/10.1016/S0025-6196(12)62768-2
  10. Chen SL, Iddings DM, Scheri RP, et al. Lymphatic mapping and sentinel node analysis: current concepts and applications. CA Cancer J Clin. 2006;56:292-309. https://doi.org/10.3322/canjclin.56.5.292
  11. Thompson JF, Uren RF. Teaching points on lymphatic mapping for melanoma from the Sydney Melanoma Unit. Semin Oncol. 2004;31:349-56. https://doi.org/10.1053/j.seminoncol.2004.03.004
  12. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420-30. https://doi.org/10.1002/1097-0142(19820601)49:11<2420::AID-CNCR2820491133>3.0.CO;2-2
  13. Uren RF, Howman-Giles RB, Thompson JF. Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy. Ann Surg Oncol. 1998;5:517-21. https://doi.org/10.1007/BF02303644
  14. Morton DL, Cochran AJ, Thompson JF, et al. Sentinel node biopsy for early-stage melanoma accuracy and morbidity in MSLT-1, an international multicenter trial. Ann Surg. 2005;242:133-42. https://doi.org/10.1097/01.sla.0000167848.96692.ad
  15. Robinson DS, Sample WF, Fee HJ, et al. Regional lymphatic drainage in primary malignant melanoma of the trunk determined by colloidal gold scanning. Surg Forum. 1977;28:147-8.
  16. McMasters KM, Chao C, Wong SL, et al. Interval sentinel lymph nodes in melanoma. Arch Surg. 2002;137:543-7. https://doi.org/10.1001/archsurg.137.5.543
  17. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-90.
  18. Haigh PI, Lucci A, Turner RR, et al. Carbon dye histologically confirms the identify of sentinel lymph nodes in cutaneous melanoma. Cancer. 2001;92:535-41. https://doi.org/10.1002/1097-0142(20010801)92:3<535::AID-CNCR1352>3.0.CO;2-3
  19. Renzi C, Caggiati A, Mannooranparampil TJ, et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: case series and review of the literature. Eur J Surg Oncol. 2007;33:364-9. https://doi.org/10.1016/j.ejso.2006.10.017
  20. Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical consideration of the procedure as performed at the John Wayne Cancer institute. J Surg Oncol. 2010;101:669-76. https://doi.org/10.1002/jso.21581